Trials / Unknown
UnknownNCT01875952
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
Integral Research of the Managing and Treatment of the Infection With Human Immunodeficiency (VIH) /Human Immunodeficiency Syndrome(SIDA) Co-infection With Latent Tuberculosis Infection. A Multidisciplinary and Interinstitucional Approach
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Instituto Nacional de Salud Publica, Mexico · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine of once identified to the subjects infected with human immunodeficiency virus (positive VIH), to diagnose latent Tuberculosis, and to treat her with isoniazid for six months, measuring the production of Interferon range pre and posttreatment, to evaluate this way the result of the treatment on the immune response
Detailed description
A descriptive analysis of the data will be made. Means and standard deviations for continuous data frequencies for categorical data will be performed. Wilcoxon test Mann-Whitney U test Chi square will be used for frequency analysis of responders Data Analysis and Statistical Software(STATA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isoniazid | Isoniazid, 10 mg/Kg/day, no more than 300 mg/day, for six months |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2012-06-01
- Completion
- 2013-06-01
- First posted
- 2013-06-12
- Last updated
- 2013-06-12
Locations
2 sites across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01875952. Inclusion in this directory is not an endorsement.